Investigators from Mass General Brigham have conducted a multi-ancestry, whole genome sequencing association study of Alzheimer’s disease and found evidence for 16 new susceptibility genes, expanding the study of Alzheimer’s disease in underrepresented groups.…

Tel Aviv University researchers used CRISPR to cut the SOX2 gene from head and neck cancer cells, eliminating 50% of tumors in mice. The study highlights CRISPR’s potential for cancer treatment.

A new study finds that aspirin may disrupt the protective shield cancer cells use to evade the immune system.

Helmholtz Munich, is a member of the Helmholtz Association of German Research Centres

Mass General Brigham research finds novel biomarkers for tinnitus that are reflective of nervous system’s “fight, flight, or freeze” response, and can be collected by filming patients while listening to unpleasant sounds.

A surprising discovery in spider brains has led scientists to uncover a hidden waste removal system in the human brain. Its breakdown may explain the progressive neuron loss seen in Alzheimer’s disease, offering a new target for early intervention.

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia, the commonest cancer in childhood and one that can be particularly difficult to treat in older patients.

Scientists found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.

Spinal cord injuries are currently incurable, with devastating effects on people’s lives, but a new study offers hope for healing.

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with Alzheimer’s disease, but that it causes them no harm. The discovery opens the door to developing new ways of treating or preventing the …

Dopamine doesn’t flood the brain as once believed – it fires in exact, ultra-fast bursts that target specific neurons. The discovery turns a century-old view of dopamine on its head and could transform how we treat everything from attention-deficit/hyperactivity…

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s, potentially slowing or even reversing its symptoms.

University of Missouri scientists discover a hidden “molecular seesaw” behind drug resistance in certain types of lung cancer, offering hope for more effective therapies.

The findings, published in Nature Genetics, offer critical insights into why some prostate cancers become resistant to therapy and how that shift could be blocked.

A groundbreaking new treatment using gene-edited immune cells, developed by scientists at Great Ormond Street Hospital (GOSH) and University College London (UCL), has shown promising results in helping children and adults fight a rare and aggressive form…

Authors of The Lancet Series on Alzheimer's Disease outline some of their findings

Background Previously the author was unable to develop a formal mathematical characterization of his probability-based hormetic relative risk (HRR) model for ca...